The following information was taken from the 2019 annual report of Bristol-Myers Squibb, a world-leading drug company (dollars in millions).

Prepare an income statement, balance sheet, and statement of cash flows, and comment on the financial performance and condition of the company. The company's year-end is December 31.

Transcribed Image Text:

$ 8,078 Cost of goods sold Net cash from operations Accounts receivable $ 4,293 12,346 3,346 Inventories Cash and equivalents Short-term borrowings Accounts payable Long-term liabilities 8,067 7,685 Income tax expense Net cash from financing Shareholders' equity Net cash from investing Research and dev. expense 1,515 2,445 7,621 51,698 (9,770) 6,148 90,045 2,073 3,047 45,553 26,145 6,252 1,988 12,513 4,871 Net sales Property, plant, and equipment Other current assets Other noncurrent assets Other current liabilities Other expenses Marketing, selling, and adm. expense Accrued payables Short-term investments 10,101